Logo image of USAS

AMERICAS GOLD AND SILVER COR (USAS) Stock Fundamental Analysis

NYSEARCA:USAS - NYSE Arca - CA03062D1006 - Common Stock - Currency: USD

0.8438  +0 (+0.21%)

After market: 0.8306 -0.01 (-1.56%)

Fundamental Rating

2

USAS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 155 industry peers in the Metals & Mining industry. USAS has a bad profitability rating. Also its financial health evaluation is rather negative. USAS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

USAS had negative earnings in the past year.
In the past year USAS has reported a negative cash flow from operations.
In the past 5 years USAS always reported negative net income.
USAS had a negative operating cash flow in each of the past 5 years.
USAS Yearly Net Income VS EBIT VS OCF VS FCFUSAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

USAS has a worse Return On Assets (-26.81%) than 83.87% of its industry peers.
USAS's Return On Equity of -89.16% is on the low side compared to the rest of the industry. USAS is outperformed by 88.39% of its industry peers.
Industry RankSector Rank
ROA -26.81%
ROE -89.16%
ROIC N/A
ROA(3y)-21.76%
ROA(5y)-29.6%
ROE(3y)-67.54%
ROE(5y)-77.36%
ROIC(3y)N/A
ROIC(5y)N/A
USAS Yearly ROA, ROE, ROICUSAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

USAS has a Gross Margin (19.23%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of USAS has grown nicely.
The Profit Margin and Operating Margin are not available for USAS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y43.19%
USAS Yearly Profit, Operating, Gross MarginsUSAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

1

2. Health

2.1 Basic Checks

USAS does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, USAS has more shares outstanding
Compared to 5 years ago, USAS has more shares outstanding
USAS has a better debt/assets ratio than last year.
USAS Yearly Shares OutstandingUSAS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
USAS Yearly Total Debt VS Total AssetsUSAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -1.75, we must say that USAS is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.75, USAS is not doing good in the industry: 88.39% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.23 indicates that USAS is not too dependend on debt financing.
The Debt to Equity ratio of USAS (0.23) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z -1.75
ROIC/WACCN/A
WACC8.82%
USAS Yearly LT Debt VS Equity VS FCFUSAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

USAS has a Current Ratio of 0.52. This is a bad value and indicates that USAS is not financially healthy enough and could expect problems in meeting its short term obligations.
USAS has a worse Current ratio (0.52) than 92.26% of its industry peers.
USAS has a Quick Ratio of 0.52. This is a bad value and indicates that USAS is not financially healthy enough and could expect problems in meeting its short term obligations.
USAS has a Quick ratio of 0.37. This is amonst the worse of the industry: USAS underperforms 91.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.37
USAS Yearly Current Assets VS Current LiabilitesUSAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.22% over the past year.
Looking at the last year, USAS shows a quite strong growth in Revenue. The Revenue has grown by 19.88% in the last year.
Measured over the past years, USAS shows a quite strong growth in Revenue. The Revenue has been growing by 11.40% on average per year.
EPS 1Y (TTM)22.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)19.88%
Revenue growth 3Y30.77%
Revenue growth 5Y11.4%
Sales Q2Q%20.82%

3.2 Future

The Earnings Per Share is expected to grow by 27.34% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 31.17% on average over the next years. This is a very strong growth
EPS Next Y80.36%
EPS Next 2Y41.42%
EPS Next 3Y27.16%
EPS Next 5Y27.34%
Revenue Next Year33.84%
Revenue Next 2Y25.66%
Revenue Next 3YN/A
Revenue Next 5Y31.17%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
USAS Yearly Revenue VS EstimatesUSAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 100M 200M 300M 400M
USAS Yearly EPS VS EstimatesUSAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2027 2028 2029 2030 2031 2032 0 0.2 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

USAS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
USAS Price Earnings VS Forward Price EarningsUSAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
USAS Per share dataUSAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 -0.1 0.15

4.3 Compensation for Growth

USAS's earnings are expected to grow with 27.16% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y27.16%

More info and screens

0

5. Dividend

5.1 Amount

USAS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMERICAS GOLD AND SILVER COR

NYSEARCA:USAS (6/6/2025, 8:04:00 PM)

After market: 0.8306 -0.01 (-1.56%)

0.8438

+0 (+0.21%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-13 2025-08-13
Inst Owners20.1%
Inst Owner Change241.76%
Ins Owners9.33%
Ins Owner Change0%
Market Cap550.46M
Analysts80
Price Target0.94 (11.4%)
Short Float %0.98%
Short Ratio2.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.72%
PT rev (3m)7.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-424.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.32%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.28
P/FCF N/A
P/OCF N/A
P/B 9.93
P/tB 9.93
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.16
BVpS0.08
TBVpS0.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.81%
ROE -89.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.23%
FCFM N/A
ROA(3y)-21.76%
ROA(5y)-29.6%
ROE(3y)-67.54%
ROE(5y)-77.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y43.19%
F-Score5
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 89.7%
Cap/Sales 20.72%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.37
Altman-Z -1.75
F-Score5
WACC8.82%
ROIC/WACCN/A
Cap/Depr(3y)88.58%
Cap/Depr(5y)98.19%
Cap/Sales(3y)20.94%
Cap/Sales(5y)26.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next Y80.36%
EPS Next 2Y41.42%
EPS Next 3Y27.16%
EPS Next 5Y27.34%
Revenue 1Y (TTM)19.88%
Revenue growth 3Y30.77%
Revenue growth 5Y11.4%
Sales Q2Q%20.82%
Revenue Next Year33.84%
Revenue Next 2Y25.66%
Revenue Next 3YN/A
Revenue Next 5Y31.17%
EBIT growth 1Y-0.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1732.34%
EBIT Next 3YN/A
EBIT Next 5Y146.33%
FCF growth 1Y-62.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-546.52%
OCF growth 3YN/A
OCF growth 5YN/A